📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Daratumumab, bortezomib and dexamethasone at first relapse for patients with multiple myeloma: A real-world multicentre UK retrospective analysis. (2023)

First Author: McMillan A

Attributed to: TRAnsFORM: Trial Assessments of Fitness and Outcomes Research in Myeloma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjh.18703

PubMed Identifier: 36822820

Publication URI: http://europepmc.org/abstract/MED/36822820

Type: Journal Article/Review

Volume: 201

Parent Publication: British journal of haematology

Issue: 4

ISSN: 0007-1048